Navigation Links
Interleukin Genetics Announces Management and Board Appointments
Date:9/6/2007

sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns and our ability to make progress in advancing our core technologies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward- looking statements include, but are not limited to, the risk of market acceptance of our products, the risk of technology and product obsolescence, delays in product development, the performance of our commercial partners, the availability of adequate capital, the actions of our competitors and other competitive risks, and those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2006 as amended, filed with the Securities and Exchange Commission, our quarterly reports on Form 10- Q and other filings made by us with the Securities and Exchange Commission. We disclaim any obligation or intention to update these forward-looking statements.

For Interleukin Genetics:

Paul Voegelin (781) 398-0700

Additional Contacts for Media / Investors:

Erin Duggan (212) 4
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Wisconsin court affirms damages in Innogenetics, Abbott patent case
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. Symposium examines the effect of race on genetics and disease
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
...re to be used in clinical trials ... July 29 The Lions Clubs of Multiple,District 5M ... Spring Point,Project, a Minnesota non-profit orga...despread availability of pig donors of islet tissu...com/cgi-bin/prnh/20071214/CLF057LOGO-b ), Spring...
...Innovations, Inc. (Amex: IMA ), a global leader i...nnounced its financial results for the quarter,end... the Company recorded net revenue of,$401.1 millio... second,quarter of 2007. The revenue increase was ...enue in our Professional Diagnostics segment which...
...ng stem cell technology to an,orphan disease, in a..., Mass. and IRVINE, Calif., July 29 ,ALS Therapy D... Cell, Inc.,(CSC) announced today a new collaborat...f stem cells in treating ALS - amyotrophic lateral.... The new set of experiments will,begin in August ...
Other Biology Technology:Spring Point Project Gains Support of Lions Clubs 2Spring Point Project Gains Support of Lions Clubs 3Inverness Medical Innovations Announces Second Quarter 2008 Results 2Inverness Medical Innovations Announces Second Quarter 2008 Results 3Inverness Medical Innovations Announces Second Quarter 2008 Results 4Inverness Medical Innovations Announces Second Quarter 2008 Results 5Inverness Medical Innovations Announces Second Quarter 2008 Results 6Inverness Medical Innovations Announces Second Quarter 2008 Results 7Inverness Medical Innovations Announces Second Quarter 2008 Results 8Inverness Medical Innovations Announces Second Quarter 2008 Results 9Inverness Medical Innovations Announces Second Quarter 2008 Results 10Inverness Medical Innovations Announces Second Quarter 2008 Results 11Inverness Medical Innovations Announces Second Quarter 2008 Results 12Inverness Medical Innovations Announces Second Quarter 2008 Results 13Inverness Medical Innovations Announces Second Quarter 2008 Results 14Inverness Medical Innovations Announces Second Quarter 2008 Results 15Inverness Medical Innovations Announces Second Quarter 2008 Results 16ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration 2ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration 3
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Papillomavirus silences innate immune response 2Species down, disease up 2Species down, disease up 3Species down, disease up 4Novel Facebook Application Aims to Prevent Cervical Cancer 59302 1Novel Facebook Application Aims to Prevent Cervical Cancer 59302 2Launch of First Year Round Annual Scientific Medical Meeting Announced at Health 2 0 59299 1Launch of First Year Round Annual Scientific Medical Meeting Announced at Health 2 0 59299 2Kidney Care Community Commends Congressional Black Caucus for Naming Expansion of Medicare Provisions for Kidney Failure Patients as Top Priority 59296 1Kidney Care Community Commends Congressional Black Caucus for Naming Expansion of Medicare Provisions for Kidney Failure Patients as Top Priority 59296 2Kidney Care Community Commends Congressional Black Caucus for Naming Expansion of Medicare Provisions for Kidney Failure Patients as Top Priority 59296 3
...hologists have long known that memories of disturb...or the unexpected death of a loved one - are more ...ne recollections of everyday matters. , Probing d...the University of Wisconsin-Madison have found tha... fire up two memory-forming regions of the brain -...
...d at first with nothing more than boots, a screen ... fish that makes up 70 percent of the biomass in T..." marking the point in evolution that led to the d..., The inch-long spineless fish, called a lancelet,...lar to but much hardier than the version found in ...
...essor of Microbiology at the Public University of ...ading an international project to sequence the gen...eam is composed of scientists from nineteen univer...apan, Israel and the United States. , The project...e annual competition of the Joint Genome Institute...
Other Biology News:Anticipation plays a powerful role in human memory, brain study finds 2Anticipation plays a powerful role in human memory, brain study finds 3Tiny Tampa Bay fish key to evolution of immune system 2Tiny Tampa Bay fish key to evolution of immune system 3Sequencing of the oyster mushroom genome 2Sequencing of the oyster mushroom genome 3Sequencing of the oyster mushroom genome 4
LabFax: Immunochemistry from Promega
Sheep Growth Hormone from Cell Sciences
Bovine Albumin from Bovine Serum, Unconjugated from Molecular Probes (Invitrogen)
Dynabeads Epithelial Enrich from Dynal Biotech
Biology Products: